Fri, Sep 19, 2014, 7:13 AM EDT - U.S. Markets open in 2 hrs 17 mins

Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

dr.vinmantoo 58 posts  |  Last Activity: Sep 17, 2014 8:01 PM Member since: May 18, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Down down down, ahahahahahaha

    by jmeilink6000 Jul 28, 2014 11:18 AM
    dr.vinmantoo dr.vinmantoo Jul 28, 2014 12:36 PM Flag

    Pgnx roc, just put the simpleton on ignore. He is an attention starved loser and you give him what he desperately wants by responding to him.you can reprt him as a spammer if that would make you feel better.

  • Reply to

    What the Market is Telling Synta

    by cadillacofminivans Jul 24, 2014 10:31 AM
    dr.vinmantoo dr.vinmantoo Jul 24, 2014 12:17 PM Flag

    Not a bad analysis cadillac. SNTA has been hurt by inept management but fortunately they are looking for an new CEO. The I-SPY 2 represents a great opportunity so I wouldn't downplay it.

  • Reply to

    3rd fail at $5

    by jmeilink6000 Jul 23, 2014 10:12 AM
    dr.vinmantoo dr.vinmantoo Jul 23, 2014 11:15 AM Flag

    pgnxrox, you are looking at this wrong. Jmelink is here to provide us with some amusement as his expense as PGNX keeps rising after he keeps telling us why it won't. It is a gift we should enjoy. He will soon be telling us PGNX won't hold $5.50. After it does, it will be it won't hold $5.75. After t does, then it won't break $6…..

    Don't get mad, just thank him for providing the laugh.

  • Reply to

    Stifel keeping a lid on it (from Fly on the Wall)

    by snt951 Jul 22, 2014 8:36 PM
    dr.vinmantoo dr.vinmantoo Jul 22, 2014 10:09 PM Flag

    There is always some contrarian.

  • Reply to

    Broadfin Capital LLC

    by ca_fisherman Jul 22, 2014 2:27 PM
    dr.vinmantoo dr.vinmantoo Jul 22, 2014 4:24 PM Flag

    Nice to see PGNX broach the $5 level. It will be nicer after it passes it for good on its way higher.

  • Reply to

    Awfully quiet folks

    by ericknl22 Jul 17, 2014 10:10 AM
    dr.vinmantoo dr.vinmantoo Jul 17, 2014 12:29 PM Flag

    Looks like another broad based market decline in biotech.

  • Reply to

    $4.15 support broken

    by ericknl22 Jul 16, 2014 1:28 PM
    dr.vinmantoo dr.vinmantoo Jul 16, 2014 2:33 PM Flag

    Eric, why are you telling us about your net worth? Most people would be shy about admitting such a low total.

  • Reply to

    More shares

    by dr_lucid Jul 16, 2014 10:12 AM
    dr.vinmantoo dr.vinmantoo Jul 16, 2014 12:38 PM Flag

    erick, you need to chill out and grab hold onto some reality. Fed chief Yellen made some ill-advised comments about specific market sectors, one of which was small biotechs. The market in these sectors immediately tanked so of course SNTA dropped. You start spouting off about how this confirms your "brilliant" stock picking prowess. Wow, talk about delusions of grandeur.

  • Reply to

    yesterdays news was widely expected

    by asif19999 Jul 15, 2014 3:42 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 4:28 PM Flag

    No such thing as ALWAYS.

  • Some have talked about the recent FDA decision on Relistor label expansion as only being a possibility. That is wrong. The FDA gave approval for label expansion. Here is the SLXP press release from yesterday.

    "On July 14, 2014, Salix Pharmaceuticals, Ltd. (the "Company") and Progenics Pharmaceuticals, Inc. ("Progenics") announced that the Food and Drug Administration had informed the Company that it had approved the supplemental New Drug Application for RELISTOR� (methylnaltrexone bromide) Subcutaneous Injection, 20 mg/ml, for the treatment of opioid-induced constipation in patients taking opioids for chronic non-cancer pain."

  • dr.vinmantoo by dr.vinmantoo Jul 15, 2014 3:34 PM Flag

    I was able to buy some more EXEL at a discount. Please mention GILD so I can buy ore of that at a discount too.

  • Reply to

    Fed is concerned

    by ericknl22 Jul 15, 2014 1:11 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 3:32 PM Flag

    The fact that Yellen actually mention small biotechs just shows that she is very new to the job. If she feels the need to comment on stocks, them make one about the broader markets, or focus on financials and housing. It was a breath-taking lay amateurish move to mention small biotechs as a concern.

  • Reply to

    Congraulations to the PGNX longs

    by dr.vinmantoo Jul 14, 2014 2:12 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 12:05 PM Flag

    scotty, I see what you meant. I would still be a bit more cautious as to the $1.2 billion figure as I think 2017 is a bit optimistic. Even the good news on Relistor, we both know there are more positives to PGNX now. Good Luck

  • Reply to

    Congraulations to the PGNX longs

    by dr.vinmantoo Jul 14, 2014 2:12 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 11:03 AM Flag

    scotty, the $1.2 billion figure for oral Relistor sales from SLPX was for several years down the road, not in the next two years.

  • Reply to

    what happened today

    by sbhatia12345 Jul 14, 2014 9:05 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 11:01 AM Flag

    kdressen, first of all, there is no IF, what I stated is fact. Second, some shorts will lie and distort in order to sow fear and thereby hope to profit from it. That is truly loathsome and our board troll jmelink is of that ilk. Put the imbecile on ignore. Obviously not all shorts are like that and shorts do play an important role in the market.

    It isn't surprising that some short term traders would book some profits and move on. When that comes on the day the market is tanking, some panic and sell or foolishly get caught on margin and are forced to sell. I look at such times as opportunities if the company's prospects are good. PGNX is now on much more solid footing, and most investors don't know that the $40 million milestone in coming to PGNX. In a few weeks, SLXP will have met with the FDA to finalize labeling issues and lay out the framework for post-approvla studies in a few weeks. The official announcement of FDA approval will be made, PGNX will get the milestone soon after. The next key for Relistor is how soon SLXP will meet with the FDA regarding ORAL Relistor, and how long its approval will take.

  • Reply to

    what happened today

    by sbhatia12345 Jul 14, 2014 9:05 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 2:52 AM Flag

    This is what SLXP will be doing in the net few weeks and then it will be official.

    ."In regard to the RELISTOR sNDA the Agency has directed Salix to work with and submit certain information to the Division of Gastroenterology and Inborn Errors Products (DGIEP). Salix intends to submit the requested information over the next several weeks. The requested information includes: proposed product labeling and a proposal(s) for one or more post-marketing observational cohort studies designed to assess the relative incidence of Major Adverse Cardiovascular Events (MACE) among chronic non-cancer pain patients initiating RELISTOR via subcutaneous injection for OIC versus a comparator cohort.
    This request for a proposal for a post-marketing observational study is in accordance with recommendations of the June 11-12, 2014 meeting of the Anesthetic and Analgesic Drug Product Advisory Committee. Salix will work with the DGIEP in an effort to provide information to the Division that will enable the Division to approve RELISTOR for use by patients with chronic non-cancer pain and experiencing OIC."

  • Reply to

    what happened today

    by sbhatia12345 Jul 14, 2014 9:05 PM
    dr.vinmantoo dr.vinmantoo Jul 15, 2014 2:47 AM Flag

    Stop lying kdreesen. SLXP does NOT have to submit new data. The will be speaking with the FDA regarding post-apporval studies.

  • especially to the long-time nodes like Striperman and cafisherman. This was a long time coming and it is a shame that the FDA engaged in CYA two years ago to delay this day. Hopefully, the FDA will allow the oral formal to be approved with minimal hoops to jump through. If you listened to the CC, PGNXZ was asked about Oral formulation approval. They were cautiously optimistic as they didn't see anything obvious that would create a road-block for Oral Relistor, but that needs to be discussed with the FDA as soon as they can and that is on the agenda.

    PGNX is also getting Azedra manufacturing back up to speed as the supplier lapsed before PGNX obtained it.

  • dr.vinmantoo dr.vinmantoo Jul 14, 2014 2:05 PM Flag

    The only money he has is the play money from his monopoly board game.

  • Reply to

    Under $4 tomorrow

    by drmlk3 Jul 14, 2014 2:01 PM
    dr.vinmantoo dr.vinmantoo Jul 14, 2014 2:03 PM Flag

    drmlk3 is another idiot I have placed on ignore.

MNTA
11.60+0.20(+1.75%)Sep 18 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.